NEW YORK ( TheStreet) -- The ex-dividend date for Meridian Bioscience (Nasdaq: VIVO) is tomorrow, November 17, 2011. Owners of shares as of market close today will be eligible for a dividend of 19 cents per share. At a price of $19.05 as of 9:38 a.m. ET, the dividend yield is 4.1%.

The average volume for Meridian Bioscience has been 287,400 shares per day over the past 30 days. Meridian Bioscience has a market cap of $760.3 million and is part of the health care sector and drugs industry. Shares are down 20.2% year to date as of the close of trading on Tuesday.

Meridian Bioscience, Inc., a life science company, engages in the development, manufacture, distribution, and sale of diagnostic test kits primarily for gastrointestinal, food borne, viral, respiratory, and parasitic infectious diseases. The company has a P/E ratio of 26.8, below the average drugs industry P/E ratio of 29.4 and above the S&P 500 P/E ratio of 17.7.
  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates Meridian Bioscience as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and premium valuation. You can view the full Meridian Bioscience Ratings Report.

See our dividend calendar or top-yielding stocks list.

If you liked this article you might like

3 Undiscovered, Undervalued Health Care Stocks Poised to Outperform the Sector in 2016

Insider Trading Alert - VIVO, CCG And PDCE Traded By Insiders

Meridian Bioscience (VIVO) Weak On High Volume

Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom

Meridian Bioscience (VIVO) Upgraded From Hold to Buy